Treasury issues an AI Lexicon and sector-specific risk management framework to guide responsible AI adoption across financial institutions.
Despite winning an FDA approval in 2023 and gaining clarity in May on the regulatory path forward for its Type 1 diabetes prospect sotagliflozin, Lexicon Pharmaceuticals hasn’t had an easy go of it in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results